Background and Aims: In GI endoscopy, biopsies must transit through the accessory channel and cap presenting an opportunity for loss of tissue. We sought to determine the incidence of specimen retention in the accessory channel or cap and identify procedure characteristics associated with specimen retention.
Methods: After completion of standard endoscopic procedures in which biopsies were obtained, the biopsy cap and accessory channel were inspected, brushed and irrigated for any retained biopsy specimens according to a standard protocol. For controls the same protocol was applied to procedures in which biopsies were not obtained. Specimen bottles from the recovery protocol were sent for pathological examination regardless if any visible tissue was present.
Results: 216 outpatient procedures were included: 55 EGDs and 50 colonoscopies in which biopsies were obtained and 56 EGDs and 55 colonoscopies in the control group. Retained specimens were found in either the cap or channel in 50/105 (48%). In 20/105 (19%) retained specimens were found just in the cap, in 6/105 (5.7%) retained specimens were found just in the channel, while in 24/105 (23%) retained specimens were found in both the cap and channel. Retained specimens were more likely to be found in EGDs compared to colonoscopies (58% vs. 36%, p=0.031). No retained specimens were found in the control group.
Conclusion: Retained specimens are startingly common in standard GI endoscopic procedures and could potentially change diagnoses and management. Quality improvement measures should be instituted to monitor prevalence of retained biopsies and methods to prevent them should be developed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.